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Zimbabwe, with an estimated HIV 
prevalence rate of 18.1%, currently has 
6 times the number of TB cases than it 
did 20 years ago when its leading TB 
NGO declared the war on TB to have 
been ‘won’.
This emerged at last November’s 
International Conference on TB 
and Lung Disease in Cape Town 
where the need for collaboration 
between TB and HIV prevention and 
treatment programmes was repeatedly 
emphasised by the world’s top TB 
experts.
Zimbabwe, on the verge of economic 
meltdown with its health system in 
tatters, has just one laboratory able to 
carry out key bacterial culture and drug 
sensitivity tests, resulting in massive 
under-diagnosing and/or inappropriate 
treatment.
Says Ellen Ndimande of the 
Zimbabwe Association for the 
Rehabilitation and Prevention of 
Tuberculosis (RAPT), ‘From 1954 we 
had an increasingly successful fight 
against TB but the past few years 
have shown us that the disease has 
re-emerged to become the number one 
killer of people with HIV’.
Progressive attitudes of little 
help
Unlike neighbouring South Africa, 
Zimbabwe declared HIV a national 
emergency in 2002 and its Minister 
of Health and Child Welfare, David 
Parirenyatwa, actually admits that 
not enough has been done to tackle 
the growing threat. He told Partners 
Zimbabwe, an affiliation of civil society 
stakeholders formed to respond more 
effectively to HIV/AIDS, TB and related 
health issues, ‘we have not done enough 
to address TB … the focus on HIV has 
largely driven our attention from TB 
and this is something we must redress 
as a matter of urgency’.
Parirenyatwa said his country had 
recently launched the fixed-dose 
combination for TB treatment which 
would make it easier for the uptake of 
drugs and adherence, but ‘much more 
work needs to be done to integrate TB 
and HIV’. He said his ministry needed 
‘to push up the management systems’ 
in order to have appropriate advocacy 
on TB. Little is known about how 
big a problem drug-resistant TB is in 
Zimbabwe, although conditions appear 
to be ideal for multidrug-resistant 
(MDR) forms to flourish.
World’s lowest treatment success 
rate
According to the latest World Health 
Organization (WHO) data, Zimbabwe 
has the lowest treatment success 
rate among all the high-burden TB 
countries, with just over half of all cases 
successfully treated. 
Without a complete course of 
antibiotics, the remainder stand a 
good chance of TB recurring in a drug-
resistant form. This can only worsen 
as current fuel shortages dramatically 
cut transport options, making trips 
to clinics and, as a result, TB drug 
adherence,  even more difficult.
Paradoxically, sky-rocketing inflation 
has made migration to neighbouring 
countries for work even more frenetic. 
Porous borders between Zimbabwe 
and South Africa provide a convenient 
gateway for drug-resistant TB to take 
the same path.
Lynde Francis, director of The Centre, 
a community-based care facility in 
Harare, said, ‘we’re sure that we are 
seeing MDRTB,  but because there is 
no laboratory that can do the culture 
or sensitivity tests we don’t have the 
evidence to prove it’.
’The government is saying that 
because we do not have any drugs for 
TB patients there is no point in testing 
for MDRTB,’ she added. One result of 
this lack of support and information 
was that people with TB were beginning 
to face virtually the same social stigma 
as people with HIV, Francis said.
Many now believed that a positive 
TB test automatically meant you were 
HIV positive as well, ‘and so they are 
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‘Margaret’ (surname unknown), 11, a TB 
patient at the NGO-supported Mashambanzou 
Clinic in Zimbabwe that started life as a paedi-
atric palliative care unit and now helps 80% of 
its children get onto TB or ARV drugs – though 
adherence is pitiful and getting worse.
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avoiding even getting tested,’ she said.
Diagnosis, management and 
treatment of TB in Zimbabwe, 
particularly among people living with 
HIV (PLHIV), could not be improved 
without significant increases in and 
acceleration of investments in services, 
as well as in patient literacy about TB.
In June 2005, a proposal to strengthen 
the national TB control programme was 
submitted to the 5th round of the Global 
Fund to Fight AIDS, Tuberculosis and 
Malaria.
enhanced tB programme just 
begun
A year-and-a-half later, the grant 
agreement was signed (December 2006), 
and today about one-third of the R82 
million (~ US$ 12 million) funds has 
reached the country and implementation 
is just commencing.
One phenomenon that has slightly 
mitigated the twin pandemics in 
Zimbabwe has been some community 
participation in home-based care 
(HBC), particularly around HIV/AIDS. 
However, with TB now the leading 
cause of death among PLHIV, lack 
of TB knowledge among these front-
line caregivers is rendering them 
increasingly desperate. Approximately 
60% of all new TB cases among 
Zimbabweans aged 15 - 49 years occur 
in HIV-positive people.
The low levels of community 
involvement in TB treatment and 
prevention were attributed by Partners 
Zimbabwe to state policies that place 
the responsibility for this solely 
in the hands of government. The 
organisation said the acute shortage of 
drugs and medical staff in the country 
was compromising TB programmes 
‘at a time when we cannot afford to 
make mistakes’. An audit of the HBC 
providers in Zimbabwe reveals that they 
are better equipped to tackle TB than the 
government.
Given the opportunity, HBC 
programmes could perform better, or at 
least complement  government’s efforts 
towards responding to TB.  A Partners’ 
spokesperson said HBC programmes 
could help with TB identification and 
treatment and help ensure adherence.
The organisations could also act as 
hubs for drug distribution through 
a decentralised directly observed 
treatment short-course (DOTS) 
programme. ‘This is critical, considering 
that public transport and hospitals 
are inaccessible to many people in the 
country,’ she added. HIV/TB campaign 
co-ordination was urgently required 
among both policy makers and donors.
’Often funding partners tell people 
implementing their programmes that 
their aid is only meant for PLHIV. This 
means that patients who have TB but 
have not yet been tested for HIV cannot 
benefit from HBC programmes.’
Success ‘impossible’ without 
integration
If policy makers and funders continued 
to remain impervious to the need 
to integrate responses to the two 
epidemics, ‘we are going to fail,’ she 
predicted.
The private health care sector’s 
Population Services International (PSI) 
said that all new patients registered with 
their post-test support services were 
screened for TB via a questionnaire. 
Dr Karin Hatzold of PSI said that if it 
was ‘considered probable’ that a patient 
had the disease, they were referred to a 
TB diagnostic centre for further clinical 
tests.
PSI is responsible for about 45% of 
voluntary counselling and testing 
 services in Zimbabwe through its New 
Start centres.
About 14% of HIV-positive patients 
treated by PSI are being referred for 
further tests.
Observers say that the only possible 
way Zimbabwe can  begin to make 
an impact on its twin pandemics is to 
‘task shift’ – allow less-qualified health 
care workers to take on tasks usually 
managed by doctors and nurses. As it is, 
most health care institutions are run by 
medical interns and unregistered nurses. 
Junior doctors earn the equivalent of 
R300 per month. 
Funding the fight against the twin 
pandemics remains one of the biggest 
challenges.
In 2006 the government budget 
allocated to addressing TB, HIV and 
MDRTB fell short by about R2.68 million 
(US$0.4million). The lack of reliable TB 
and HIV data to support collaborative 
activities is another major stumbling 
block. Zimbabwe has no figures at all 
from 2005.
The WHO told  Cape Town 
conference delegates that Zimbabwe’s 
efforts to address the needs arising 
from widespread HIV/TB co-infection 
were ‘still in the developmental stage’. 
A lack of integrated and speedy 
implementation would ‘spell disaster,’ 
the WHO spokesman warned.
Indicators of health care system 
failure include a maternal mortality 
ratio that exceeds 550 per 100 000 and 
a 50% rise in under-5 mortality since 
1990. People requiring public sector 
hospitalisation must bring their own 
drips, IV fluids and needles. Vacancy 
rates at these institutions vary from 44% 
(nurses) to 89% (technicians).
Many of the urban poor among the 
700 000 whose homes were destroyed in 
the infamous Operation Murambatsvina 
(drive out trash) have been unable to re-
establish themselves on drug treatment 
after dispersal to remote areas outside 
Harare.
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The organisation said the 
acute shortage of drugs 
and medical staff in the 
country was compromising 
TB programmes ‘at a time 
when we cannot afford to 
make mistakes’.
pg14-22indd.indd   16 12/20/07   10:18:15 AM
